Family planning use and fertility desires among women living with HIV in Kenya Global health

listen audio

Study Justification:
This study examines the use of family planning (FP) services by HIV-positive and HIV-negative women in Kenya and their ability to achieve their fertility desires. The study is important because enabling women living with HIV to effectively plan whether and when to become pregnant is a fundamental right. Additionally, preventing unintended pregnancies is crucial for reducing maternal morbidity and mortality, as well as vertical transmission of HIV.
Highlights:
– 13% of the women sampled were HIV-positive at baseline.
– HIV-positive women were more likely to use FP in the last 12 months and to use dual methods of contraception compared to HIV-negative women.
– Short-acting contraceptives were the most commonly used FP methods for both HIV-positive and HIV-negative women.
– HIV-positive women were more likely to have unintended pregnancies and a desire not to have more children.
– After adjusting for confounding factors, HIV-positive women were significantly more likely to use dual methods of FP.
– Factors associated with FP use were type of health facility, marital status, and household wealth status.
– Factors associated with fertility desires were age, education level, and household wealth status.
Recommendations:
– Strengthen family planning services for women living with HIV to ensure better access to a wide range of FP methods.
– Encourage the use of long-acting reversible contraceptives (LARC) to reduce the risk of unintended pregnancy and vertical transmission of HIV.
– Policies should be based on respect for women’s right to informed reproductive choice in the context of HIV/AIDS.
Key Role Players:
– Health facility providers: Trained in provision of integrated HIV and FP services using a Balanced Counselling Strategy Plus algorithm (BCS+).
– Policy makers: Responsible for developing and implementing policies that strengthen family planning services for women living with HIV.
– Research staff: Conducted the study and collected data.
Cost Items for Planning Recommendations:
– Training of health facility providers in integrated HIV and FP services.
– Development and implementation of policies to strengthen family planning services.
– Research staff salaries and expenses for data collection.
Please note that the cost items provided are for planning purposes and do not reflect actual costs.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong. The study utilized a random sample of women seeking family planning services in public health facilities in Kenya and collected data through a longitudinal study. Descriptive statistics and multivariate logistic regression analysis were used to examine the relationship between family planning use, fertility desires, and HIV status. The study identified important gaps in family planning utilization among women living with HIV and highlighted the need to strengthen family planning services for this population. To improve the strength of the evidence, future studies could consider increasing the sample size and conducting a more comprehensive analysis of factors associated with family planning use and fertility desires among women living with HIV.

Background: Enabling women living with HIV to effectively plan whether and when to become pregnant is an essential right; effective prevention of unintended pregnancies is also critical to reduce maternal morbidity and mortality as well as vertical transmission of HIV. The objective of this study is to examine the use of family planning (FP) services by HIV-positive and HIV-negative women in Kenya and their ability to achieve their fertility desires. Methods: Data are derived from a random sample of women seeking family planning services in public health facilities in Kenya who had declared their HIV status (1887 at baseline and 1224 at endline) and who participated in a longitudinal study (the INTEGRA Initiative) that measured the benefits/costs of integrating HIV and sexual/reproductive health services in public health facilities. The dependent variables were FP use in the last 12 months and fertility desires (whether a woman wants more children or not). The key independent variable was HIV status (positive and negative). Descriptive statistics and multivariate logistic regression analysis were used to describe the women’s characteristics and to examine the relationship between FP use, fertility desires and HIV status. Results: At baseline, 13 % of the women sampled were HIV-positive. A slightly higher proportion of HIV-positive women were significantly associated with the use of FP in the last 12 months and dual use of FP compared to HIV-negative women. Regardless of HIV status, short-acting contraceptives were the most commonly used FP methods. A higher proportion of HIV-positive women were more likely to be associated with unintended (both mistimed and unwanted) pregnancies and a desire not to have more children. After adjusting for confounding factors, the multivariate results showed that HIV-positive women were significantly more likely to be associated with dual use of FP (OR∈=∈3.2; p∈<∈0.05). Type of health facility, marital status and household wealth status were factors associated with FP use. Factors associated with fertility desires were age, education level and household wealth status. Conclusions: The findings highlight important gaps related to utilization of FP among WLHIV. Despite having a greater likelihood of reported use of FP, HIV-positive women were more likely to have had an unintended pregnancy compared to HIV-negative women. This calls for need to strengthen family planning services for WLHIV to ensure they have better access to a wide range of FP methods. There is need to encourage the use of long-acting reversible contraceptive (LARC) to reduce the risk of unintended pregnancy and prevention of vertical transmission of HIV. However, such policies should be based on respect for women's right to informed reproductive choice in the context of HIV/AIDS. Trial registration: NCT01694862

The Integra Initiative was a multi-country research study measuring the feasibility, effects and costs of integrated HIV and sexual and reproductive health services in Kenya and Swaziland. The integrated HIV and FP service model developed explicit linkages with FP services and relevant HIV/AIDS services, and enabling linkage with antiretroviral therapy (ART) services for eligible clients, either on-site or through referral to other health facilities. Before recruitment of participants, providers in study intervention facilities were trained in provision of integrated services using a Balanced Counselling Strategy Plus algorithm (BCS+) and a standardised mentorship strategy described elsewhere [33]. Study implementation begun after intervention-facility providers were certified as attaining a pre-determined minimum level of clinical skills. To be eligible for inclusion in the FP-HIV study, the women had to be aged 15 years and over, be revisit FP clients, be living in the catchment area of the health facility, and willing to give their informed consent to be interviewed. The study methodology used to evaluate the intervention is described in detail elsewhere [34]. The data were collected through the INTEGRA Initiative – a multi-country research study measuring the benefits and costs of integrated HIV and sexual and reproductive health services (www.integrainitiative.org). The study sample was selected randomly from women seeking family planning services at 12 public health facilities in Kenya. Participants were recruited between November 2009 and May 2010 as a cohort of women using FP that were followed for 24 months during which measures were made three times to determine trends in several reproductive health indicators, including fertility desires, pregnancy status (both planned and unintended), consistency in use of FP, and HIV status. A total of 1959 women were recruited at baseline, of which 1636 (83.5 %) were reported being HIV-negative and 251 (12.8 %) reported being HIV-positive; 72 women declined to report their HIV status. At endline, 1224 women remained in the cohort, of which 1068 (87.3 %) were HIV-negative and 156 (12.7 %) were HIV-positive. For this analysis, we used baseline and endline data only, and included only women willing to report their HIV status. The desired sample size of 1959 was calculated to test the larger study hypothesis that exposure to the FP model of intervention would lead to an increase in condom use in addition to another contraceptive method by at least 5 percent among sexually active women over two years and to allow for 30 % loss-to-follow up. The women were recruited from 12 public health facilities which were purposively selected based on provision of a minimum range of services (FP, voluntary counseling and testing (VCT), STI treatment, and PMTCT) and a minimum number of FP clients (100 or more per month). The health facilities were located in peri-urban and rural areas of five counties in Kenya; the facilities comprised four hospitals and eight health centres. All women seeking FP services from the health facilities on the days when the research team was present were approached for recruitment until the desired sample size was reached. For inclusion, the women had to be aged 15 years and over, live in the catchment area of the health facility, and give their informed consent to be interviewed. All adolescents 15 – 17 years were only interviewed following parental consent. A closed-ended questionnaire was used to collect data on women’s fertility intentions, pregnancy, use of FP, other SRH and STI/HIV-related behaviors and health-seeking behaviors. Women were also asked whether they ever had an HIV test, whether they knew their status, and if so, whether they were willing to voluntarily disclose their status. There was no pressure for them to disclose their HIV status and unwillingness to do so was not a criterion for exclusion from participating in the INTEGRA study. Trained research assistants conducted the interviews using hand-held personal digital assistants (PDAs) loaded with the questionnaire tool translated into Swahili. Every respondent was given a full description of the study and gave their informed consent in writing prior to interview. Descriptive, bivariate and multivariate analyses were carried out using STATA ® version 10. The descriptive and bivariate analyses were used to describe the characteristics of the sample and explore the associations between FP use in the last 12 months, fertility desires and the woman’s HIV status. Chi-square (X2) and Fisher’s Exact tests were used for bivariate analyses. Multivariate logistic regression analysis was conducted to examine these relationships controlling for potential confounding factors (including marital status, education, and household socioeconomic status (SES) identified in previous research [21, 30, 35–37]. The analysis models included an interaction term between HIV status and timing of data collection to assess changes in FP use and fertility desires over time. Table 1 summarizes the operational definitions for the study variables. Definition of variables in the analysis aHousehold SES was computed using the principal component analysis technique and the items used for computation included ownership of different household items such as television, radio, bicycle and use of different types of sources of fuel for cooking The study was approved by the Kenya Medical Research Institute (KEMRI) Ethical Review Board (IRB approval numbers 113 and 114), the Population Council’s Institutional Review Board (IRB approval numbers 443 and 444), and the Ethics Review Committee of the London School of Hygiene & Tropical Medicine (LSHTM) (IRB approval number 5426). The Integra Initiative is registered on the Clinical Trials registration site: ClinicalTrials.gov Identifier: {"type":"clinical-trial","attrs":{"text":"NCT01694862","term_id":"NCT01694862"}}NCT01694862. All research staff were trained and certified in research ethics. Written informed consent was obtained from all participants.

N/A

Based on the study titled “Family planning use and fertility desires among women living with HIV in Kenya,” the recommendation to improve access to maternal health is to strengthen family planning services for women living with HIV (WLHIV) in Kenya. This can be achieved by ensuring that WLHIV have better access to a wide range of family planning methods, including long-acting reversible contraceptives (LARC).

The study found that although a slightly higher proportion of HIV-positive women were using family planning services compared to HIV-negative women, HIV-positive women were more likely to have had unintended pregnancies. By promoting the use of LARC, the risk of unintended pregnancies can be reduced, which is crucial for both maternal health and the prevention of vertical transmission of HIV.

Additionally, it is important to consider the respect for women’s right to informed reproductive choice in the context of HIV/AIDS when implementing policies related to family planning services for WLHIV.

Please note that the study was conducted as part of the Integra Initiative, a multi-country research study measuring the feasibility, effects, and costs of integrated HIV and sexual and reproductive health services in Kenya and Swaziland. The study methodology involved training providers in integrated services and collecting data through interviews with women seeking family planning services in public health facilities in Kenya. The study was approved by ethical review boards and followed research ethics guidelines.
AI Innovations Description
Based on the information provided, the recommendation to improve access to maternal health is to strengthen family planning services for women living with HIV (WLHIV) in Kenya. This can be achieved by ensuring that WLHIV have better access to a wide range of family planning methods, including long-acting reversible contraceptives (LARC).

The study found that although a slightly higher proportion of HIV-positive women were using family planning services compared to HIV-negative women, HIV-positive women were more likely to have had unintended pregnancies. By promoting the use of LARC, the risk of unintended pregnancies can be reduced, which is crucial for both maternal health and the prevention of vertical transmission of HIV.

Additionally, it is important to consider the respect for women’s right to informed reproductive choice in the context of HIV/AIDS when implementing policies related to family planning services for WLHIV.

This recommendation is based on the findings of the study titled “Family planning use and fertility desires among women living with HIV in Kenya” published in BMC Public Health in 2015.
AI Innovations Methodology
To simulate the impact of the main recommendations on improving access to maternal health, a potential methodology could involve the following steps:

1. Identify a representative sample of women living with HIV (WLHIV) in Kenya who are accessing family planning services.
2. Collect data on their current use of family planning methods, including the proportion of women using long-acting reversible contraceptives (LARC).
3. Assess the prevalence of unintended pregnancies among WLHIV and compare it to the prevalence among HIV-negative women.
4. Implement an intervention to strengthen family planning services for WLHIV, focusing on improving access to a wide range of family planning methods, including LARC.
5. Monitor the uptake of family planning services and the use of LARC among WLHIV after the intervention.
6. Collect data on unintended pregnancies among WLHIV post-intervention and compare it to the pre-intervention data.
7. Analyze the data to determine the impact of the intervention on reducing unintended pregnancies among WLHIV.
8. Assess the cost-effectiveness of the intervention by comparing the costs of implementing the intervention to the potential savings in maternal health expenses.
9. Consider the ethical implications of the intervention, ensuring that women’s right to informed reproductive choice is respected in the context of HIV/AIDS.
10. Disseminate the findings of the simulation study to relevant stakeholders, including policymakers, healthcare providers, and organizations working in maternal health and HIV/AIDS.

By following this methodology, researchers can evaluate the effectiveness of strengthening family planning services, particularly the promotion of LARC, in improving access to maternal health for WLHIV in Kenya. The findings can inform future policies and interventions aimed at reducing unintended pregnancies and improving maternal health outcomes for WLHIV.

Partilhar isto:
Facebook
Twitter
LinkedIn
WhatsApp
Email